ACKR3 and gastric neoplasm: The activation of CXCR7 facilitates gastric tumour progression by modulating YAP phosphorylation and nuclear localization, while pharmaceutically targeting CXCR7 via ACT could promote YAP phosphorylation and cytosol retention, which subsequently inhibit gastric tumour growth.